About: Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.80 (-2.98%)
BNTC NASDAQ Benitec Biopharma Inc.
Benitec Biopharma Inc. share price
BNTC price activity
Last Price
$8.800
Change (24hr)
-0.27 USD (-2.98%)
Volume
44.93K
Volume (4w avg)
-
Open
$9.08
Day Range
$8.80 - $9.08
Previous Close
$9.07
Last Trade
13 Oct, 5:28 pm GMT+0
Delayed
13 Oct, 5:28 pm GMT+0
BNTC price performance
Delayed
13 Oct, 5:28 pm GMT+0
BNTC Market Signals